Work

Combinations of the Histone Deacetylase Inhibitor Entinostat (SNDX-275, MS-275) and Imatinib Have Divergent Effects in Imatinib-Sensitive Vs. Imatinib-Resistant p210-BCR/ABL Expressing Cell Lines.

Year: 2009

Type: article

Source: Blood

DOI: 10.1182/blood.v114.22.2742.2742

Authors: Rachel E. Rau, Emily McIntyre, Scott H. Kaufmann, Igor Espinoza-Delgado, Judith Karp, Patrick Brown

Institutions: Johns Hopkins University, Mayo Clinic, National Cancer Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2547020151

FWCI:

Cites:

Cited by:

Related to: 10